Dry Ice
Our AI-driven platform helps you effortlessly locate the most effective Dry Ice protocols from research literature, preprints, and patents.
With side-by-side comparisons, you can identify the best Dry Ice methods and products to unlock reproducible research.
Experiance the future of protocol discovery today.
Most cited protocols related to «Dry Ice»
For histological sections (Fig
The different reasons for exclusion were not influenced by age at diagnosis (Table
The Stockholm–Gotland Breast Cancer Registry, supplemented with patient records, were examined for information on the tumor size, the number of retrieved and metastatic axillary lymph nodes, the hormonal receptor status, distant metastases, the site and date of relapse, initial therapy, therapy for possible recurrences, the date and cause of death. Tumor sections from the primary tumors from patients with array profiles were classified using Elston–Ellis grading [18 (link)] by a blinded pathologist (HN).
In the adjuvant setting tamoxifen and/or goserelin is normally used for hormonal treatment, but mostly intravenous cyclophosphamide, methotrexate and 5-fluorouracil (CMF) on days 1 and 8 was used as adjuvant chemotherapy, except in high-risk patients who were offered inclusion in the Scandinavian Breast Group 9401 study [19 (link)]. After primary therapy, patients were recommended to have regular clinical examinations and yearly mammograms, in addition to laboratory and X-ray tests guided by clinical signs and symptoms. Patients were normally followed for 5 years. Patients followed up outside the Karolinska Hospital were tracked using a unique personal identification number. There was no loss to follow-up.
The relapse site, date of relapse, relapse therapy and date of death were ascertained in May 2002. The average follow-up was 6.1 years. Cause of death was coded as death due to breast cancer (including those with distant metastases but dying from other causes), death due to other malignancies and death due to nonmalignant disorders. Through the population-based Swedish Cancer Registry, second primary malignancies were identified.
Blood samples for A1C were obtained at baseline and monthly for 3 months. The blood samples were frozen at −80° C and were sent on dry ice by overnight shipment to the central laboratory. Samples were analyzed with four different DCCT-aligned assays, including a high-performance liquid chromatography assay (Tosoh G7; Tosoh Bioscience, Tokyo, Japan), two immunoassays (Roche A1C and Roche Tina-quant; Roche Diagnostics), and an affinity assay (Primus Ultra-2; Primus Diagnostics, Kansas City, MO). The mean A1C value was used. The laboratory assays were approved by the National Glycohemoglobin Study Program (10 (link)) and have intra- and interassay coefficients of variation <2.5% for low and high values. The assays were highly intercorrelated with R2 values of 0.99 and slopes of ∼1.0 and intercepts between 0.01 and 0.18. Any samples that demonstrated “aging peaks” on high-performance liquid chromatography, evidence of degradation during storage and/or shipment, were considered unacceptable for analysis. One center in Asia was unable to store samples acceptably, resulting in samples that could not be assayed for A1C. The center was eliminated from the study.
Most recents protocols related to «Dry Ice»
Example 105
The parent nucleotide 5′-phosphoramidate (0.1 mmol) was suspended in triethylamine (5 mL) and distilled water (5 mL) in a round bottom flask at room temperature. The reaction mixture was stirred at 37° C. for 24 hours, and then the solvents were removed under reduced pressure. The crude residue was purified on silica eluting with 2-propanol, water, ammonia (8:1:1). The fractions containing the desired product were pooled and concentrated under reduced pressure to remove most of the volatiles. The remaining aqueous solution was transferred to a vial, and was then frozen in a dry ice/acetone bath. The material was then freeze-dried to provide the desired product as a white solid.
Example 1
A 1 L stirred reactor from Parr Instruments was used to prepare polyamide 6 particles by melt emulsification. The reactor was loaded with 20 wt % polyamide 6 and 80 wt % 10,000 cSt PDMS oil. The mixture was then heated to 225° C. while stirring at 1000 rpm using a dual 4-blade propeller. After about 60 minutes, the mixture was discharged from the reactor onto dry ice to quench the mixture. The mixture was then filtered and washed to recover the polymer particles. The resultant polymer particles were passed through a 150-μm sieve. Approximately, 40 wt % of the polyamide 6 loaded into the reactor passed through the 150-μm sieve.
With Clatskanie, OR, being a mesic site in the Columbia River Delta with a high water table, trees were grown without supplemental irrigation. With Boardman, OR, typically only receiving approx. 18 cm of rainfall annually, trees were supplemented with irrigation water. Surprisingly, there were no significant differences in the total metabolite concentrations between drought-stressed and well-watered trees within a given genotype (data not shown).
Top products related to «Dry Ice»
More about "Dry Ice"
It is widely used for sample preservation, temperature regulation, and cold chain logistics.
Researchers in fields like molecular biology, biochemistry, and cell biology often employ Dry Ice to maintain the integrity and stability of temperature-sensitive samples, such as DNA, RNA, proteins, and cell cultures.
The deep-freezing capabilities of Dry Ice help prevent degradation and ensure reproducible results in experiments.
Techniques like RNA extraction, utilizing reagents like TRIzol and RNeasy Mini Kit, often rely on Dry Ice to chill samples during the process and preserve the delicate RNA molecules.
Similarly, cryosectioning with a cryostat (e.g., CM3050S) and mounting tissue samples on Superfrost Plus slides benefit from the cooling properties of Dry Ice to maintain sample morphology.
Preserving samples in RNAlater solution is another common application of Dry Ice, as it helps stabilize and protect RNA from degradation during transport and storage.
Downstream analyses, such as those performed on the Agilent 2100 Bioanalyzer, can then be conducted on these high-quality samples.
The use of Dry Ice is not limited to the lab; it is also essential in the cold chain logistics of temperature-sensitive materials, including pharmaceutical and biomedical products.
Tissue-Tek OCT compound, for example, is often used in conjunction with Dry Ice to maintain the structural integrity of tissue samples during storage and transportation.
Discover the power of PubCompare.ai, an AI-driven platform that helps researchers effortlessly locate the most effective Dry Ice protocols from research literature, preprints, and patents.
With side-by-side comparisons, you can identify the best Dry Ice methods and products to unlock reproducible research and experiance the future of protocol discovery today.